大禹生物
(920970)
| 流通市值：5.88亿 | | | 总市值：9.30亿 |
| 流通股本：7007.13万 | | | 总股本：1.11亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 22,100,328.32 | 45,824,856.62 | 52,589,902.75 | 25,674,833.74 |
| 交易性金融资产 | - | - | 63,149 | - |
| 应收票据及应收账款 | 21,812,372.57 | 22,625,762.82 | 20,907,077.14 | 20,545,383.32 |
| 应收账款 | 21,812,372.57 | 22,625,762.82 | 20,907,077.14 | 20,545,383.32 |
| 应收款项融资 | 94,250 | - | - | - |
| 预付款项 | 3,984,376.64 | 4,525,487.18 | 3,481,693.46 | 2,535,887.49 |
| 其他应收款合计 | 85,565.07 | 67,270.45 | 101,569.25 | 42,052.5 |
| 存货 | 65,245,822.16 | 34,049,215.87 | 23,189,556.19 | 19,147,617.4 |
| 其他流动资产 | 740,737.62 | 740,737.62 | 743,050.88 | 754,413.35 |
| 流动资产合计 | 114,063,452.38 | 107,833,330.56 | 101,075,998.67 | 68,700,187.8 |
| 非流动资产: | | | | |
| 固定资产 | 265,536,816.53 | 272,401,306.89 | 275,067,805.52 | 281,630,446.71 |
| 在建工程 | 17,405,768.52 | 4,206,521.13 | 403,895.54 | - |
| 使用权资产 | 9,974,254.99 | 8,896,450.22 | 4,942,281.73 | - |
| 无形资产 | 24,627,198.15 | 24,924,733.56 | 25,222,268.97 | 25,519,804.38 |
| 其他非流动资产 | 23,950,711.64 | 17,743,872.64 | 19,360,351.64 | 17,533,495 |
| 非流动资产合计 | 341,494,749.83 | 328,172,884.44 | 324,996,603.4 | 324,683,746.09 |
| 资产总计 | 455,558,202.21 | 436,006,215 | 426,072,602.07 | 393,383,933.89 |
| 流动负债: | | | | |
| 短期借款 | 84,000,000 | 74,000,000 | 79,100,000 | 60,060,431.37 |
| 应付票据及应付账款 | 15,215,010.8 | 9,207,679.67 | 7,110,757.36 | 7,518,860.21 |
| 应付账款 | 15,215,010.8 | 9,207,679.67 | 7,110,757.36 | 7,518,860.21 |
| 合同负债 | 4,044,107.16 | 1,523,392.59 | 1,606,288.25 | 1,259,629.98 |
| 应付职工薪酬 | 7,413,807.25 | 7,799,827.08 | 7,188,526.81 | 7,575,144.43 |
| 应交税费 | 444,821.97 | 694,670.13 | 237,599.81 | 545,284.4 |
| 其他应付款合计 | 809,644.86 | 469,368.9 | 254,852.66 | 209,605.66 |
| 一年内到期的非流动负债 | 3,096,449.53 | 2,627,522.16 | 76,441.37 | - |
| 流动负债合计 | 115,023,841.57 | 96,322,460.53 | 95,574,466.26 | 77,168,956.05 |
| 非流动负债: | | | | |
| 长期借款 | 15,075,000 | 12,500,000 | - | - |
| 租赁负债 | 9,455,236.83 | 8,282,397.74 | 4,609,811.69 | - |
| 递延收益 | 33,354,582.21 | 34,558,332.24 | 35,762,082.27 | 22,849,165.63 |
| 非流动负债合计 | 57,884,819.04 | 55,340,729.98 | 40,371,893.96 | 22,849,165.63 |
| 负债合计 | 172,908,660.61 | 151,663,190.51 | 135,946,360.22 | 100,018,121.68 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 111,360,400 | 111,360,400 | 111,360,400 | 111,360,400 |
| 资本公积 | 85,593,738.02 | 85,593,738.02 | 85,593,738.02 | 85,593,738.02 |
| 减:库存股 | 5,109,738.08 | 5,109,738.08 | 5,109,738.08 | 5,109,738.08 |
| 盈余公积 | 16,853,068.95 | 16,853,068.95 | 16,853,068.95 | 16,853,068.95 |
| 未分配利润 | 73,952,072.71 | 75,645,555.6 | 81,428,772.96 | 84,668,343.32 |
| 归属于母公司股东权益合计 | 282,649,541.6 | 284,343,024.49 | 290,126,241.85 | 293,365,812.21 |
| 股东权益合计 | 282,649,541.6 | 284,343,024.49 | 290,126,241.85 | 293,365,812.21 |
| 负债和股东权益合计 | 455,558,202.21 | 436,006,215 | 426,072,602.07 | 393,383,933.89 |
| 公告日期 | 2025-10-27 | 2025-08-25 | 2025-04-28 | 2025-04-28 |
| 审计意见(境内) | | | | 标准无保留意见 |